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A quantitative understanding of the ef-
fects exerted by hydrophobic or amphi-
philic drugs and biomolecules on
biological membrane function is not
possible without parsing the problem
into membrane partitioning and the
actual trigger that induces the response
under study. This problem and its
solution are not exactly new, but they
have been and continue to be ignored
in many cases. In the previous issue of
the Biophysical Journal, Collins and
Gordon (1) compare the effects on
channel proteins such as TRPV1 of
water-soluble, short-chain phosphati-
dylinositol phosphates (PIPs) used in
patch-clamp electrophysiology and
their membrane-bound, long-chain
counterparts found in cells. The authors
demonstrate the importance of explic-
itly accounting for membrane partition-
ing when studying receptor binding and
present a rigorous way to do one’s
homework properly. Their results imply
the need to revisit previous in vitro data
on the activation ofmembrane channels
by water-soluble lipid analogs. But this
is only the tip of the iceberg.
The key to interpreting a binding
experiment of a hydrophobic or amphi-
philic ligand to a membrane protein
lies in distinguishing among threeSubmitted September 23, 2013, and accepted for
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0006-3495/13/12/2607/4 $2.00states of the ligand, that is, in aqueous
solution (aq), in the lipid bilayer (b),
and complexed to the protein (c).
Thus, it takes two parameters—for
example, the membrane–water parti-
tion coefficient, KP, and the dissocia-
tion constant of the protein–ligand
complex, KD—to describe the distribu-



















molar concentrations of the ligand or
additive (A) in the aqueous phase, in
the bilayer, and complexed to the recep-
tor protein, respectively. The symbol
cL stands for the concentration of lipid
(L) accessible to the additive, and cR
f
is the concentration of free binding
sites on the receptor (R). In this nota-
tion, each concentration refers to the
respective molar amount in the total
volume of the system; hence, according
to Eqs. 1 and 2, KP and KD come in
units of inverted molarity and molarity,
respectively (see Heerklotz (2) for
a discussion of various definitions of
partition coefficients). KP is often
referred to as an apparent partition
coefficient,Kapp, to indicate that it com-
prises the net effects of both hydro-
phobic and electrostatic interactions
and, for ionic additives such as PIPs,
will thus vary with the surface charge
density of the membrane (1,2). The
parameter Rb ¼ cAb/cL denotes the
additive/lipid mole ratio within the
membrane and, thus, may serve as a
measure of membrane composition.
Note that, although KD as defined in
Eq. 2 refers to the equilibrium of the
additive between the protein site and
the aqueous solution, it is unequivo-
cally linked to the composition of the
membrane through Eq. 1. Thus, mecha-
nistic details, including the question
whether the additive accesses the recep-
tor directly from the aqueous solution
or from the membrane, are irrelevantfor the following thermodynamic
considerations.
For demonstration purposes, we
assume simple 1:1 binding, but more
complex models may apply. If, for
instance, serum albumins or other car-
riers are used to solubilize the ligand,
the model has to be expanded to
explicitly account for the presence
of the carrier–ligand complex in the
aqueous phase. The same holds for
other linked equilibria such as micelle
formation or adsorption of the ligand
to the walls of the measurement cham-
ber, which can be treated implicitly
by resorting to nominal rather than
actual concentrations or, more satisfy-
ingly, in an explicit manner using an
appropriate model (3). However, such
refinements needed in specific cases
for experimental reasons would not
change the general conclusions dis-
cussed below. In our simple model,
mass conservation requires
cA ¼ caqA þ cbA þ ccA; (3)
with cA denoting the total concentra-
tion of ligand. Analogously, the total
receptor concentration, cR, comprises
free and occupied populations:
cR ¼ cfR þ ccA: (4)
We have solved the system of Eqs. 14
to simulate the distribution of additive
among the three states as a function of
the total concentrations of additive, re-
ceptor, and lipid. An example is given
in Fig. 1, which depicts the aqueous
fraction of additive (blue) and the
fractional occupancy of the receptor
(red) as functions of the total additive
concentration (top) or the membrane
composition in terms of Rb (bottom).
The figure illustrates three important
facts:
1. When it comes to equilibrium
binding, the membrane actually
competes with the receptor for
the ligand. Only for low lipid








































FIGURE 1 (A and C) Fraction of additive that is in aqueous solution, cA
aq/cA (blue), and (B and D)
fractional occupancy of the receptor, cA
c/cR (red), as functions of the total ligand concentration, cA
(top), and the additive/lipid mole ratio in the membrane, Rb (bottom). Simulations were done for
KP ¼ 1 mM1, KD ¼ 10 mM, cR/cL ¼ 1:1000, and cL ¼ 0.01 mM (bold solid), 0.1 mM (thin solid),
1 mM (dash-dot), 10 mM (dashed), or 100 mM (dotted line).
2608 Heerklotz and Kellerconcentrations and weak partition-
ing (so thatKPcL 1) can the mem-
brane-bound fraction of ligand be
neglected. This results from the
expression for the membrane-bound
fraction (excluding protein-bound
ligand) obtained by combining





2. The intrinsic, unequivocal abscissa
for a protein binding or activation
plot is either Rb (Fig. 1, bottom) or
cA
aq. By contrast, a curve givenBiophysical Journal 105(12) 2607–2610versus total ligand concentration,
cA, depends on the lipid concentra-
tion in the assay (Fig. 1, top) and,
thus, is not unequivocal and virtu-
ally impossible to interpret quanti-
tatively. Trivially, the same applies
to additives such as surfactants (4)
and peptides (5) that directly act
on membranes without involving
membrane proteins.
3. The membrane has very appropri-
ately been called a catalyst for
ligand binding to membrane pro-
teins (for a review, see Vauquelin
and Packeu (6)). As a catalyst, it
does not change the affinity in termsof KD. What it might change, how-
ever, is the kinetics of binding,
which is crucial for response times
in signaling or turnover of an
enzyme. Note that micellization,
serum albumins, or whatever else
may help solubilize the ligand in
solution (i.e., lowers its chemical
potential) has the same effect as
the membrane: it may speed up
the kinetics of receptor binding
but, thermodynamically, competes
with the receptor for the ligand.
A number of approaches have been
developed to deal with these issues.
In their binding assay of a ligand to a
G-protein-coupled receptor, Seeman
et al. (7) explicitly measured both
cA
aq and cA
c and then modeled the
unequivocal plot of cA
c as a function
of cA
aq. Collins and Gordon (1) make
use of the (in their case, very good)
approximation that, owing to the low
concentration of protein, the protein-
bound fraction of ligand is negligible,
cA
c/cA z 0. Hence, KP of the ligand
to the membrane can be measured in
the absence of receptor and may then
be used to convert cA to Rb, the proper
abscissa, for the lipid concentration
used in the receptor activation experi-
ment. The simplest case is one in
which both the receptor concentration
(cA
c/cA z 0) and the lipid concentra-
tion or partition coefficient (KPcL 
1) are low. If both of these conditions
are fulfilled, one may assume that
virtually all ligand is in solution, and
the proper abscissa, cA
aq, follows
from the approximation cA
aq z cA.
Let us, on a broader note, have a
look into the mechanistic roles of
the membrane during the activation
of a protein or process by a ligand
or, more generally, by a membrane-in-
teracting additive. For the point of the
argument, we consider two extreme
scenarios, in which membrane parti-
tioning of an additive and the response
of the membrane system resemble
either a serial or a parallel circuit. In
the serial case, the response of the
membrane system is a direct conse-
quence of the insertion of the additive
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brane partitioning is a prerequisite for
the effect under study. In the parallel
case, membrane partitioning is an
alternative to and, thus, only competes
with receptor binding or whatever else
evokes the response of the membrane
system.
The parallel scenario is applicable
to ligands that are able to equilibrate
with a high-affinity site on a membrane
protein. The activation of TRPV1 by
PIPs as discussed by Collins and Gor-
don (1) exemplifies this case, because
PIPs directly bind to TRPV1 and
thereby activate the channel. From a
thermodynamic viewpoint, membrane
partitioning of short-chain PIPs is not
a prerequisite for TRPV1 activation,
but it nevertheless manifests itself
by changing the PIP concentration in
the aqueous phase, cA
aq. However, there
is more to this than just correcting
for the actual ligand concentration
in solution. Water-soluble, short-chain
PIPs are used in electrophysiological
measurements as proxies of their phys-
iologically relevant long-chain coun-
terparts, whose solubility in aqueous
solution is negligibly low. Thus, the
latterwill be found virtually exclusively
in the membrane-bound state, and it is
the membrane composition in terms
of Rb or the mole fraction within the
membrane, Xb ¼ Rb/(1 þ Rb), as used
by Collins and Gordon (1) that repre-
sents the intrinsic, meaningful abscissa
for an activation curve characterizing
the interaction of PIPs with TRPV1.
Unlike the total concentration, cA,
use ofRb enables a quantitative compar-
ison of bilayer concentrations between
short-chain PIPs under experimental
conditions and long-chain PIPs in
the plasma membrane. Similar consid-
erations apply to other association
reactions within membranes (8) or
membrane-mimetic systems such as
detergent micelles (9,10).
In the serial case, the activation
of the membrane process is a direct
consequence of the incorporation of
the additive into the membrane. KD is
not important or not even defined.
This is, for example, to be expected ifa protein is activated by more or less
random collisions of the membrane-
bound additive with a low-affinity
interaction site. Even without direct
contact, additives may activate pro-
teins by changing membrane pro-
perties such as mechanical tension,
spontaneous curvature, thickness and
order, electrostatic potential, etc. (11).
Trivially, serial behavior will be found
if a process is directly happening in
the lipid bilayer. There is no such thing
as a protein-bound state in the first
place when a surfactant solubilizes
a membrane (4), when an antibiotic
peptide causes leakage (5), or when
a curvature-active additive promotes
or inhibits fusion intermediates. Note
that serial, that is, bilayer-controlled
behavior might also be found in mea-
surements of protein activity rather
than equilibrium binding if the rate-
limiting step is the kinetics of a ligand
to reach a binding site within or
beyond the membrane (6). An example
is transmembrane pumping of sub-
strates by P-glycoprotein, which shows
maximum turnover at a specific bal-
ance between KP and KD, as discussed
by Li-Blatter et al. (12).
More than 100 years ago, Meyer
(13) and Overton (14) came up with
the classical example of separating
the effects of partitioning and activa-
tion. They compared the active con-
centrations of a diverse set of general
anesthetics to their oil–water partition
coefficients. The very good correla-
tion they found for many compounds
implies either that the affinities of all
these narcotics from the membrane to
specific binding sites on membrane
proteins are substantial yet virtually
identical (which seems very unlikely)
or that anesthesia is—in our words—
a serial process to membrane partition-
ing. The latter interpretation is also
supported by the fact that squeezing
anesthetics out of the membrane (e.g.,
by high pressure) does not increase
binding to the protein, as would be
expected in the parallel scenario, but
instead inhibits anesthesia. Part of
the controversy seems to result from
the misconception that a membrane-controlled process excludes, a priori,
direct and to some degree specific in-
teractions of the membrane constitu-
ents with proteins.
A similar correlation of biological
activity with partitioning has also
been found by Ingo´lfsson and An-
dersen (11) for amphiphilic additives
activating gramicidin channels. They
explained this serial effect convinc-
ingly by additive-induced alterations
of the mechanical properties of the
membrane. Stay tuned for an impres-
sive study of the effects of anaesthetics
on the critical behaviour of cell mem-
branes by Veatch and coworkers (15)
in an upcoming issue of the Biophysi-
cal Journal. These authors considered
partitioning implicitly (yet elegantly)
by correlating the thermodynamic
effects with biological function.
In summary, whenever the effect of
an additive on a membrane system is
concerned, one needs to consider its
membrane partitioning—irrespective
of whether the additive exerts its effect
by changing generic membrane prop-
erties or binds specifically to a protein.
Even in the latter case, one may
neglect the bilayer-bound fraction of
additive only if KPcL  1. Whenever
this condition is not met, activation
curves should be presented as a func-
tion of membrane composition or the
actual composition of the aqueous
phase after correction for membrane
partitioning. Collins and Gordon (1)
show in detail how to do this for
the case of water-soluble, short-chain
PIPs, and they exemplify the drastic
consequences this may have for the
interpretation of ligand binding studies
performed in the presence of a mem-
brane system.
We thank JamesW.Wells (University of Toronto,
Toronto, Ontario, Canada) and Klaus Gawrisch
(National Institutes of Health, Bethesda, MD)
for inspiring hints and discussions.REFERENCES
1. Collins, M., and S. Gordon. 2013. Short-
chain phosphoinositide partitioning into
plasma membrane models. Biophys. J.
105:2485–2494.Biophysical Journal 105(12) 2607–2610
2610 Heerklotz and Keller2. Heerklotz, H. 2008. Interactions of surfac-
tants with lipid membranes.Q. Rev. Biophys.
41:205–264.
3. Bruno, M. J., R. E. Koeppe, 2nd, and O. S.
Andersen. 2007. Docosahexaenoic acid al-
ters bilayer elastic properties. Proc. Natl.
Acad. Sci. USA. 104:9638–9643.
4. Keller, S., H. Heerklotz,., A. Blume. 2006.
Thermodynamics of lipid membrane solubi-
lization by sodium dodecyl sulfate. Biophys.
J. 90:4509–4521.
5. Patel, H., C. Tscheka, ., H. Heerklotz.
2011. All-or-none membrane permeabiliza-
tion by fengycin-type lipopeptides from
Bacillus subtilis QST713. Biochim. Biophys.
Acta. 1808:2000–2008.
6. Vauquelin, G., and A. Packeu. 2009.
Ligands, their receptors and...plasma mem-
branes. Mol. Cell. Endocrinol. 311:1–10.Biophysical Journal 105(12) 2607–26107. Seeman, P., C. Ulpian,., J. W. Wells. 1984.
Dopamine receptor parameters detected by
[3H]spiperone depend on tissue concentra-
tion: analysis and examples. J. Neurochem.
43:221–235.
8. Chen, L., M. Merzlyakov, ., K. Hristova.
2009. Energetics of ErbB1 transmembrane
domain dimerization in lipid bilayers.
Biophys. J. 96:4622–4630.
9. Fleming, K. G. 2002. Standardizing the free
energy change of transmembrane helix–helix
interactions. J. Mol. Biol. 323:563–571.
10. Fisher, L. E., D. M. Engelman, and J. N.
Sturgis. 2003. Effect of detergents on the
association of the glycophorin A transmem-
brane helix. Biophys. J. 85:3097–3105.
11. Ingo´lfsson, H. I., and O. S. Andersen. 2011.
Alcohol’s effects on lipid bilayer properties.
Biophys. J. 101:847–855.12. Li-Blatter, X., A. Beck, and A. Seelig. 2012.
P-glycoprotein-ATPase modulation: the mo-
lecular mechanisms. Biophys. J. 102:1383–
1393.
13. Meyer, H. 1899. The theory of alcohol
narcosis [Zur Theorie der Alkoholnarkose].
Arch. Exp. Pathol. Pharmakol. 42:109–118.
14. Overton, E. 1901. Studies on the Anesthetic
[Studien u¨ber die Narkose]. Fischer, Jena,
Germany.
15. Gray, E., J. Karslake, B. B. Machta, and
S. L. Veatch. 2013. Liquid general
anesthetics lower critical temperatures in
plasma membrane vesicles. Biophys. J.
http://dx.doi.org/10.1016/j.bpj.2013.09.035
(in press).
